He Yuan Li Ji Scholarship │ Support Wan "Li" and wish you to publish your paper in the Year of the Rabbit!
As the ancient saying goes, 'Red rabbits bring great auspiciousness, while white rabbits bring great auspiciousness.' In the Year of the Rabbit, one will have the good fortune of climbing step by step。
So! Qiang Qiang! The 2023 Fuyao Wan "Li" Scholarship Program of He Yuan Li Ji has been launched. Anyone who specifies the use of He Yuan Li Ji products in their published literature and whose impact factors meet the conditions can apply for the scholarship.
The raging fire has already gained momentum, and Guimao is even more new. Thank you for your continuous support and trust. We look forward to working together with Yuan Liji in the new year, guarding the tree to find rabbits on the road of scientific research, and guarding the tree to obtain rabbits！
1、 Reward Standards
Category of publication | Influencing factors | scholarship |
abroadSCI | IF＞20 | 2288 |
abroadSCI | 20≥IF＞10 | 1288 |
abroadSCI | 10≥IF＞5 | 688 |
abroadSCI | 5≥IF＞1 | 388 |
Domestic journals | / | 200 |
2、 Precautions
1、It is necessary to indicate in the article that the product was purchased from Huayuan Liji (Shanghai) Biotechnology Co., Ltd. The format is determined according to the requirements of SCI journals. Our English name is: Shanghai Life iLab Biotech Co., Ltd. The journal includes (Life iLab, China), (Life iLab, Shanghai, China)
for example：Cell Counting Kit-8 (Life-iLab, Shanghai, China)；
2、The impact factor (IF) of SCI journals is based on the number of points at the time of publication of the article；
3、Each article can only be applied for once, and the same author can only apply for the scholarship for the SCI article with the highest IF score; Applicants who use the same product to publish multiple articles can only redeem one scholarship with the highest impact factor；
4、Applying for a scholarship is considered as agreeing to use the full text data and images of Yuan Liji for promotional purposes；
5、The applicant must be the first author and the application period is from January 1, 2023 to December 31, 2023. Applicants should ensure the authenticity and validity of the submitted information. If they submit false information, impersonate the original author's identity, or have their manuscript withdrawn due to plagiarism or fraud, the applicant must return all scholarships and bear all relevant legal responsibilities；
6、The applicant needs to cooperate with the staff of Yuan Liji to submit the necessary documents for applying for scholarships. For application and consultation, please contact the relevant salesperson.
3、 Previous paper presentation
paper1：Local hyperthermia therapy induces browning of white fat and treats obesity
Journal: Cell Cover Issue
Influencing factors：41.582
Publication time：2022year3month5day
Thesis URL：https://doi.org/10.1016/j.cell.2022.02.004
Using Li Ji product: EZ Trans cell transfection reagent (efficient) item number：AC04L091/AC04L092
paper2：Large-Scale Multiplexed Mosaic CRISPR Perturbation in the Whole Organism
periodical：Cell
Influencing factors：66.850
Published on: July 22, 2022
Thesis URL：https://doi.org/10.1016/j.cell.2022.06.039
Product Name: EZ Trans Cell Transfection Reagent (High Efficiency) Product Code: AC04L091/AC04L092
paper3：Dietary ketone body-escalated histone acetylation in megakaryocytes alleviates chemotherapy-induced thrombocytopenia
Journal: STM Cover Issue
Influencing factors：19.319
Published on November 30th, 2022
Thesis URL：http://doi.org/10.1126/scitranslmed.abn9061
Using Li Ji product: EZ PCR direct expansion mouse tail lysate item number：AN11L227/AN11L228
paper4：Brown-fat-mediated tumour suppression by cold-altered global metabolism
periodical：Nature
Influencing factors：69.504
Published on: August 3, 2022
Thesis URL：https://www.nature.com/articles/s41586-022-05030-3
Using Li Ji product: EZ ECL Pico chemiluminescence solution (ultra sensitive type) item number：AP34L024/AP34L025
……
For more papers, please visitPaper AwardPage View
Heyuan Liji is a domestic biological reagent company established in 2023 through a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, integrating research and development, production, and sales. It focuses on the fields of life sciences and biotechnology, and is committed to providing customers with advanced technology, convenient and easy-to-use, and cost-effective products. Its product range includes experimental reagents and reagent kits related to cell biology, molecular biology, immunology, and biochemistry.
Currently, authorized agents are available in over 40 cities across the country; There are over a thousand direct service terminals, covering CROs, pharmaceutical companies, universities, hospitals, and research institutes; Li Ji's products have helped clients publish hundreds of SCI papers and multiple CNS papers.
Back
